Key Performance
More- Earnings Score: N/A
- Momentum Score: 28
- True Yield: N/A
- Financial Health Score: N/A
%20scale(1,1)}%2025%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(0.85,0.85)}%2050%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(0.7,0.7)}%2075%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(0.85,0.85)}%20100%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(1,1)}}%20%23ewMkZ6d8Hun3_ts%20{animation:%20ewMkZ6d8Hun3_ts__ts%204000ms%20linear%20infinite%20normal%20forwards}@keyframes%20ewMkZ6d8Hun3_ts__ts%20{%200%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(1,1)}%2025%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(0.85,0.85)}%2050%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(0.7,0.7)}%2075%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(0.85,0.85)}%20100%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(1,1)}}%20]]%3e%3c/style%3e%3cdefs%3e%3clinearGradient%20id='ewMkZ6d8Hun2-fill'%20x1='12.5'%20y1='23.5001'%20x2='-0.868518'%20y2='16.4047'%20spreadMethod='pad'%20gradientUnits='userSpaceOnUse'%20gradientTransform='translate(0%200)'%3e%3cstop%20id='ewMkZ6d8Hun2-fill-0'%20offset='0%25'%20stop-color='%23FF2F00'/%3e%3cstop%20id='ewMkZ6d8Hun2-fill-1'%20offset='100%25'%20stop-color='%23FF9100'/%3e%3c/linearGradient%3e%3clinearGradient%20id='ewMkZ6d8Hun3-fill'%20x1='31.5059'%20y1='27.1026'%20x2='10.2884'%20y2='14.9373'%20spreadMethod='pad'%20gradientUnits='userSpaceOnUse'%20gradientTransform='translate(0%200)'%3e%3cstop%20id='ewMkZ6d8Hun3-fill-0'%20offset='4.7%25'%20stop-color='%23FF2F00'/%3e%3cstop%20id='ewMkZ6d8Hun3-fill-1'%20offset='100%25'%20stop-color='%23FF9100'/%3e%3c/linearGradient%3e%3c/defs%3e%3cg%20id='ewMkZ6d8Hun2_ts'%20transform='translate(24.943161,19.954806)%20scale(1,1)'%3e%3cpath%20d='M14.8466,29.2814c0,0-14.408088-4.6983-12.05895-19.79995c0,0,1.50345,4.85085,4.13448,5.30845s-2.03592,4.6373,7.92447,14.4915Z'%20transform='translate(-24.943161,-19.954806)'%20fill='url(%23ewMkZ6d8Hun2-fill)'/%3e%3c/g%3e%3cg%20id='ewMkZ6d8Hun3_ts'%20transform='translate(24.9787,20.012362)%20scale(1,1)'%3e%3cpath%20d='M37.4922,21.9282l4.0719.244v-12.81353C31.0713,3.28748,17.7595,7.6502,17.7595,7.6502c.3445-4.51526-3.5707-5.52204-3.5707-5.52204c2.5371,1.52542.3132,6.22373.3132,6.22373C13.0299,0.084092,0,1.02986,0,1.02986C8.92672,4.35528,6.70287,7.98579,6.8908,16.6197c.18794,8.6034,8.3943,12.9966,8.3943,12.9966l-6.60895-.2441v13.2407c0,0,5.48135,2.3797,13.68765,3.1729v-22.3017h-4.4477c-1.0023,0-1.942-.8237-1.942-1.8v-5.7356c0-.9763.9397-1.8,1.942-1.8h4.4477v-1.3424h5.0115v1.3424h5.0115c1.0023,0,1.848.7932,1.848,1.8v5.7356c0,.9763-.8144,1.8-1.848,1.8h-5.0115v22.5153h.2819c11.1192-.0611,15.9428-7.3221,16.256-13.3017.4698-7.7492-6.421-10.7695-6.421-10.7695Z'%20transform='translate(-24.9787,-20.012361)'%20fill='url(%23ewMkZ6d8Hun3-fill)'/%3e%3c/g%3e%3c/svg%3e)
Latest Research & News
NNOX INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Nano-X Imaging Ltd.
Law firm Kirby McInerney LLP is investigating Nano-X Imaging Ltd. for potential federal securities law violations following the company's announcement of a $33.4 million net loss in Q4 2025, including a $17.5 million asset impairment charge related to its Korean chip manufacturing facility restructuring. The announcement triggered a 25% stock price decline from $2.85 to $2.15 per share on April 20, 2026, and prompted CFO Ran Daniel's resignation effective July 31, 2026.
05/05/2026, 6:00 PM • GlobeNewswire
Pomerantz LLP is investigating potential securities fraud claims against Nano-X Imaging Ltd. following the company's announcement of a $33.4 million net loss for Q4 2025, including a $17.5 million asset impairment charge related to its Korean chip manufacturing facility restructuring. The announcement triggered a 24.39% stock price decline. The company's CFO is also stepping down effective July 31, 2026.
04/28/2026, 5:40 PM • GlobeNewswire
Kirby McInerney LLP is investigating Nano-X Imaging Ltd. for potential securities law violations following the company's announcement of a $33.4 million net loss in Q4 2025, including a $17.5 million asset impairment charge related to its Korean chip manufacturing facility restructuring. The announcement triggered a 25% stock price decline from $2.85 to $2.15 per share on April 20, 2026, and prompted CFO Ran Daniel's resignation effective July 31, 2026.
04/27/2026, 8:22 PM • GlobeNewswire
The Schall Law Firm has launched a fraud investigation into Nano-X Imaging Ltd. (NNOX) on behalf of investors, examining whether the company issued false or misleading statements. Nano-X reported a $17.5 million impairment charge related to its Korean chip manufacturing facility in Q4 2025 and announced its CFO's departure in July, triggering a 25% stock price decline.
04/26/2026, 10:30 PM • GlobeNewswire
Law firm Bragar Eagel & Squire is investigating Nano-X Imaging Ltd. for potential federal securities law violations following the company's announcement of a $33.4 million net loss in Q4 2025, including a $17.5 million asset impairment charge related to its Korean chip manufacturing facility restructuring. The news triggered a 25% stock price decline from $2.85 to $2.15 per share on April 20, 2026, and prompted CFO Ran Daniel's resignation effective July 31, 2026.
04/23/2026, 5:40 PM • GlobeNewswire
Nanox Announces $15 Million Registered Direct Offering of Common Stock
Nanox has entered into a securities purchase agreement with an institutional investor to sell 3,826,530 ordinary shares, expecting to raise approximately $15 million for working capital and corporate growth initiatives.
11/23/2025, 11:26 PM • GlobeNewswire
Nanox is collaborating with Monarch Medical Management to deploy advanced medical imaging solutions across workers' compensation, nursing homes, and outpatient clinics, with plans to establish a comprehensive imaging network nationwide.
09/18/2025, 8:00 AM • GlobeNewswire
Peers
Statistics
MoreInformation as of 06/02/2026
Company Profile
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. It provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source; and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists; Nanox.CONNECT to receive local regulatory approvals and explore and evaluate the business model and the potential service; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data of existing computed tomography scans; and Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers and mobile imaging service providers, urgent care facilities, and multi-specialty physician groups. In addition, the company provides Real+ Osteoporosis Care Management Platform, a osteoporosis care management software platform; AI-Based Aortic Valve Calcification Measurement, an artificial intelligence"based solution; AI-Based Body Composition Measurement, an artificial intelligence"based body composition analysis capability; and Nanox Health IT, a healthcare information technology services provider that serves hospitals and other healthcare organizations. Nano-X Imaging Ltd. was founded in 2011 and is headquartered in Petah Tikva, Israel.